ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد

Doses for parenteral antibiotics for the empiric treatment of community-acquired pneumonia in hospitalized children

Doses for parenteral antibiotics for the empiric treatment of community-acquired pneumonia in hospitalized children
Agent Regimen[1,2] Comments
Ampicillin
  • 150 to 200 mg/kg per day in 4 divided doses (MAX 12 g/day)
 
Azithromycin
  • 10 mg/kg once per day on days 1 and 2 of therapy (MAX 500 mg/day)
  • 5 mg/kg once per day on subsequent days of therapy (MAX 250 mg/day)
  • Transition to oral therapy at 5 mg/kg per day as soon as clinically appropriate
Cefazolin
  • 100 to 150 mg/kg per day in 3 divided doses (MAX 12 g/day)
  • Limited data on doses >100 mg/kg per day
Cefotaxime
  • 150 mg/kg per day in 3 or 4 divided doses (MAX 8 g/day)
  • The 4-dose regimen should be used for severe infection or substantial local penicillin resistance
Ceftaroline
  • Age ≥2 months and <2 years: 8 mg/kg every 8 hours
  • Age ≥2 and <18 years:
    • Weight ≤33 kg: 12 mg/kg every 8 hours
    • Weight >33 kg: 400 mg every 8 hours or 600 mg every 12 hours
  • Age ≥18 years: 600 mg every 12 hours
  • Experience with ceftaroline in children with documented MRSA infection is limited
Ceftriaxone
  • 50 to 100 mg/kg per day in 1 or 2 divided doses (MAX 4 g/day)
  • The 100 mg/kg per day dose should be used only if local rates of penicillin resistance to Streptococcus pneumoniae are substantial (eg, ≥25%)
  • The 2-dose regimen should be used for severe infection or if local rates of penicillin resistance to S. pneumoniae are substantial (eg, ≥25%)
Clindamycin
  • 30 to 40 mg/kg per day in 3 or 4 divided doses (MAX 2.7 g/day)
 
Doxycycline
  • 4 mg/kg per day in 2 divided doses (MAX 200 mg/day)
  • Transition to oral therapy as soon as clinically appropriate
Erythromycin
  • 20 mg/kg per day in 4 divided doses (MAX 4 g/day)
  • Parenteral erythromycin is associated with phlebitis, prokinetic, and cardiotoxic effects (rare)
Levofloxacin
  • Age 6 months and <5 years: 16 to 20 mg/kg per day in 2 divided doses
  • Age ≥5 to 16 years: 8 to 10 mg/kg once per day (MAX 750 mg)
  • Fluoroquinolones may prolong QTc interval; avoid use in patients with:[3]
    • Long QT syndrome
    • Hypokalemia or hypomagnesemia
    • Organic heart disease (eg, congestive heart failure; requiring a class Ia antiarrhythmic drug*, particularly quinidine)
    • Concurrent use of other medications that prolong the QTc interval
Linezolid
  • Age <12 years: 10 mg/kg every 8 hours (MAX 600 mg/dose)
  • Age ≥12 years: 600 mg every 12 hours
 
Nafcillin
  • 150 to 200 mg/kg per day in 4 or 6 divided doses (MAX 12 g/day)
 
Penicillin G
  • For therapy: 200,000 to 250,000 units/kg per day in 4 or 6 divided doses (MAX 24 million units/day)
 
Vancomycin
  • 40 to 60 mg/kg per day in 3 or 4 divided doses (MAX 4 g/day)
 
This table is meant for use with UpToDate content on the treatment of community-acquired pneumonia in children. Refer to related UpToDate content for details about choice of therapy. Consultation with a specialist in pediatric infectious diseases is suggested for children with severe hypersensitivity to beta-lactam antibiotics (eg, penicillins and cephalosporins). The recommended doses are for children with normal kidney function.

MAX: maximum dose; MRSA: methicillin-resistant Staphylococcus aureus.

* Class Ia antiarrhythmic drugs include quinidine, ajmaline, disopyramide, and procainamide.

¶ Alternative dosing is suggested for clinicians/institutions who follow AUC-guided therapeutic monitoring for vancomycin for serious MRSA infections as suggested by consensus guidelines[4]; this strategy requires input from a clinical pharmacist, who will provide recommendations for initial dosing. Refer to UpToDate content on invasive staphylococcal infections in children for details of trough-guided and AUC-guided vancomycin dosing.
References:
  1. American Academy of Pediatrics. Tables of antibacterial drug dosages. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.876.
  2. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:e25.
  3. American Academy of Pediatrics. Fluoroquinolones. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.864.
  4. Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2020; 77:835.
Graphic 127763 Version 5.0